The BALANCE model would have allowed Part D plans to opt into the program to provide coverage for GLP-1 drugs for weight loss for their enrollees
Life's busy, and sometimes you need just a little something to keep you going
Those on the highest dose lost an impressive average of 70.3 pounds, which equates to a 28.3% weight reduction over 80 weeks
DeFord said a key to his weight loss was realizing he needed to treat his relationship to food as any other addiction
This helps the body get used to the medicine and lowers the chance of side effects like nausea or upset stomach
One sample report involving a patient, provided by Ro, showed a summary of the insurance coverage, supply availability and estimated copay for each drug, including Wegovy, Ozempic, Eli Lilly's weight loss injection Zepbound and compounded semaglutide, the active ingredient in Novo Nordisk's GLP-1s